Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
COSMAX is a leading global contract development/manufacturing organization specializing in cosmetics (“K-beauty”), skincare/personal care products, dietary supplements (“health functional foods”), and select medical supplies/devices. With headquarters in South Korea and major operations across Asia-Pacific/North America/Australia regions, it serves over three thousand brand partners—including most top-tier beauty multinationals—by providing end-to-end R&D/formulation/design/manufacture services under strict quality standards certified internationally. While not a traditional pharma or biotech innovator with its own clinical-stage pipeline or proprietary drugs, it plays an essential role enabling commercialization of new consumer health/wellness solutions worldwide through its advanced technical platforms and large-scale GMP-compliant facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on COSMAX.